Pipeline
Singularity Development Path
With two programs already in motion and additional opportunities in development, Singularity’s pipeline is built for momentum. Below is our projected path forward.
Program #1: Acute Pain in Fragile Patients
Family / Product
Lead Optimization
IND Enabling Studies
IND Filing
SING 2XXX-3XXX Series
SING XXXX / Back-Up
Program #2: Acute Pain in Fragile Patients
Family / Product
Lead Optimization
IND Enabling Studies
IND Filing
SING 4XXX Series
SING 5XXXX Series /
New Indication
Value inflection – Clinical candidate selection
Value inflection – Clinic-ready asset